Myeloproliferative Neoplasms

The OncLive Myeloproliferative Neoplasms condition center is a comprehensive resource for clinical news and expert insights on myeloproliferative neoplasms, including myelofibrosis, polycythemia vera, and essential thrombocythemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in myeloproliferative neoplasms.

Latest News

Phase 1/2 Trial Pauses Enrollment for Evaluation of MGTA-117 in AML/MDS After Patient Death
Phase 1/2 Trial Pauses Enrollment for Evaluation of MGTA-117 in AML/MDS After Patient Death

January 26th 2023

Magenta Therapeutics has voluntarily paused enrollment for a phase 1/2 trial evaluating the antibody-drug conjugate MGTA-117 in patients with relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome following the death of a patient.

FDA Accepts sNDA for Avapritinib in Indolent Systemic Mastocytosis
FDA Accepts sNDA for Avapritinib in Indolent Systemic Mastocytosis

January 23rd 2023

Ruxolitinib/Pegylated Interferon Alpha 2a Reduces Spleen Length in Myelofibrosis
Ruxolitinib/Pegylated Interferon Alpha 2a Reduces Spleen Length in Myelofibrosis

January 23rd 2023

TP-3654 Showcases Early Signs of Tolerability, Clinical Activity in Myelofibrosis
TP-3654 Showcases Early Signs of Tolerability, Clinical Activity in Myelofibrosis

January 17th 2023

Imetelstat Provides Durable Transfusion Independence in Lower-Risk MDS
Imetelstat Provides Durable Transfusion Independence in Lower-Risk MDS

January 4th 2023

Video Series
Video Interviews
Podcasts

More News